SCHEMBL24205657

SCHEMBL24205657

CCOC(=O)CC(C)OC(=O)CCCCC(=O)OC(C)CC(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
CYP1A2 P05177 1/20 0.47
ALDH1A1 P00352 3/20 0.43
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 1/20 0.42
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
KMT2A Q03164 2/20 0.40
PRKCA P17252 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKCQ Q04759 1/20 0.40
PRKCD Q05655 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23159138 0.95 LMNA (0.58) LMNACYP1A2ALDH1A1MAPTMAPK1
SCHEMBL21725258 0.95 LMNA (0.58) LMNACYP1A2ALDH1A1MAPTMAPK1
SCHEMBL26073642 0.93 LMNA (0.43) LMNACYP1A2ALDH1A1MAPTMAPK1
SCHEMBL21725260 0.93 LMNA (0.61) LMNACYP1A2ALDH1A1MAPTMAPK1
SCHEMBL29308241 0.93 LMNA (0.61) LMNACYP1A2ALDH1A1MAPTMAPK1
SCHEMBL24205655 0.92 GAA (0.44) LMNACYP1A2ALDH1A1GAAMGAM
SCHEMBL9656170 0.89 ALDH1A1 (0.41) LMNACYP1A2ALDH1A1GAAMAPT
SCHEMBL9656163 0.89 ALDH1A1 (0.41) LMNACYP1A2ALDH1A1GAAMAPT
SCHEMBL25985792 0.85 MGAM (0.39) LMNACYP1A2ALDH1A1GAAMAPT
SCHEMBL23159139 0.81 LMNA (0.59) LMNAALDH1A1MAPTMAPK1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116917264-A Process for preparing hydroxybutyric acid carboxylic ester 凯托利皮克斯治疗有限责任公司 2023-10-20 CN disclosed
US-20230303478-A1 PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS OF HYDROXYBUTANOATES KETOLIPIX THERAPEUTICS GMBH (DE) 2023-09-28 US disclosed
US-20230303478-A1 PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS OF HYDROXYBUTANOATES KETOLIPIX THERAPEUTICS GMBH (DE) 2023-09-28 US disclosed
EP-4146338-A1 PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS OF HYDROXYBUTANOATES KetoLipix Therapeutics GmbH (DE) 2023-03-15 EP disclosed
WO-2022012765-A1 PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS OF HYDROXYBUTANOATES IOI OLEO GMBH (DE) 2022-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303478-A1 PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS OF HYDROXYBUTANOATES HAO2, HSD17B12, HCAR3 LMNA 3241/4885CYP1A2 231/4885ALDH1A1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.